Condition
    Moderate Evidence
    Effectiveness 2/5

    Omega-3 Fatty Acids for Scleroderma

    No supplement has trial evidence for modifying scleroderma — omega-3's plausible vascular and anti-inflammatory logic is unproven here, and management belongs with rheumatology-led organ monitoring.

    Overview

    No supplement has trial evidence for modifying scleroderma — omega-3's plausible vascular and anti-inflammatory logic is unproven here, and management belongs with rheumatology-led organ monitoring.

    Verdict

    Insufficient evidence

    How It Works

    Omega-3s shift prostaglandin balance toward vasodilation and reduce inflammatory signalling — theoretically relevant to scleroderma's vascular component, but theory has not translated into demonstrated clinical benefit.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Not recommended as treatment; 1-2 g EPA+DHA daily is reasonable for general cardiovascular health if desired
    Expected timeframe
    N/A

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    Evidence is insufficient: no controlled trial has shown that omega-3 improves skin fibrosis, Raynaud attacks or lung function in systemic sclerosis. Doses of 1-3 g/day combined EPA+DHA studied in other inflammatory conditions produced no scleroderma-specific outcomes. Immunosuppression, vasodilators for digital ischaemia and screening for pulmonary hypertension and interstitial lung disease are what matter.
    titration
    Not applicable
    starting dose
    Not applicable as an established treatment

    Evidence

    What the studies say

    Scleroderma evidence is limited to small, uncontrolled, or negative studies; no randomised trial shows omega-3 changing disease course, skin scores, or organ outcomes in systemic sclerosis. The evidence-based backbone is rheumatology care: ACE inhibitors for renal protection, immunotherapy for lung involvement, and Raynaud's management. Vitamin D repletion is reasonable for bone health but likewise does not modify the disease.

    No studies are yet linked to both Omega-3 Fatty Acids and Scleroderma.

    Safety

    Caveats

    Immune-stimulating supplements (echinacea, high-dose medicinal mushrooms) are theoretically unwise in autoimmune disease. Blood-thinning caution with other anticoagulants.

    Less likely to help if

    Everyone: no responder group has been demonstrated in systemic sclerosis.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.